🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: DTPa-IPV

Found 0 matching trials

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

PHASE4

The new formulation administered as a 4th consecutive dose will be compared...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-02-14

Trial ID

NCT00611559

Treatments Being Tested

Infanrix™ penta Infanrix™ hexa

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

PHASE2

The purpose of this study is to assess the immunogenicity, safety and react...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-10-14

Trial ID

NCT01453998

Treatments Being Tested

Infanrix hexa Prevenar 13 GSK217744

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

PHASE3

This phase 3b study will compare the immunogenicity and reactogenicity of t...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-04-01

Trial ID

NCT00871000

Treatments Being Tested

Boostrix Polio™ 711866 Priorix Tetra TM 208136 Tetravac TM

Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib

PHASE3

The purpose of this trial is to evaluate the immunogenicity and safety of a...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-04-01

Trial ID

NCT00652951

Treatments Being Tested

GSK Biologicals´ Pneumococcal Conjugate Vaccine GSK1024850A (Synflorix™)Infanrix™ hexa.Pediacel™Prevenar™

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

PHASE3

This protocol posting deals with objectives \& outcome measures of the exte...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-05

Trial ID

NCT00322335

Treatments Being Tested

Haemophilus influenzae type b- and meningococcal (vaccine)Infanrix™ penta Infanrix™ hexa Engerix-B NeisVac-C™Infanrix™ IPV/HIB Meningitec™

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

PHASE3

The purpose of this trial is to assess if the rate of febrile reactions fol...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-07-02

Trial ID

NCT00496015

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A.Infanrix hexa.Meningococcal vaccine GSK134612.Paracetamol.

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

PHASE4

The purpose of this study was to assess the safety and immunogenicity of GS...

Status

Completed

Location

GSK Investigational Site

Start Date

2021-05-26

Trial ID

NCT04535037

Treatments Being Tested

DTPa-HBV-IPV/Hib DTaP5-HBV-IPV-Hib Pneumococcal 13-valent conjugate vaccine

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

PHASE3

This protocol posting deals with objectives \& outcome measures of an exten...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-05-14

Trial ID

NCT00891176

Treatments Being Tested

MenitorixTM Pneumococcal conjugate vaccine GSK1024850A PrevenarTM MeningitecTM NeisVac-CTM InfanrixTM hexa InfanrixTM penta InfanrixTM IPV/Hib InfanrixTM IPV

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

PHASE3

The purpose of this phase IIIb study is to determine whether children who h...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-09-18

Trial ID

NCT00345358

Treatments Being Tested

Synflorix Infanrix IPV/Hib

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

PHASE3

The purpose of this booster study is to evaluate the immune persistence in ...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-10-01

Trial ID

NCT01449812

Treatments Being Tested

Infanrix+Hib™Poliorix™

Previous Next